ACTIVE HALF-LIFE
2-4 days
CLASSIFICATION
Non-steroidal aromatase inhibitor
DOSAGE
2.5-5 mg/day
ACNE
No
WATER RETENTION
No
HBR
No
HEPATOTOXICITY
No
AROMATIZATION
No
MANUFACTURER
Deus Medical
LAB TEST
See Document
WAREHOUSE
EU Warehouse 2
SUBSTANCE
Letrozole
Introducing FEMAMED 2.5 (Letrozole), a premium non-steroidal aromatase inhibitor specifically designed for hormonal treatment in breast cancer management. Estrogen, a key player in the growth of certain breast cancers, is effectively targeted by this powerful medication.
FEMAMED 2.5 works by significantly lowering estrogen levels in your body. It achieves this by inhibiting the aromatase enzyme, responsible for estrogen production, thus helping to slow down the progression of estrogen-dependent breast cancer.